WGS
GeneDx Holdings Corp
Price:  
129.33 
USD
Volume:  
442,296.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

WGS WACC - Weighted Average Cost of Capital

The WACC of GeneDx Holdings Corp (WGS) is 7.7%.

The Cost of Equity of GeneDx Holdings Corp (WGS) is 7.60%.
The Cost of Debt of GeneDx Holdings Corp (WGS) is 11.95%.

Range Selected
Cost of equity 6.40% - 8.80% 7.60%
Tax rate 0.30% - 0.60% 0.45%
Cost of debt 8.30% - 15.60% 11.95%
WACC 6.4% - 9.0% 7.7%
WACC

WGS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.71
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 8.80%
Tax rate 0.30% 0.60%
Debt/Equity ratio 0.02 0.02
Cost of debt 8.30% 15.60%
After-tax WACC 6.4% 9.0%
Selected WACC 7.7%

WGS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for WGS:

cost_of_equity (7.60%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.55) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.